Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant melanoma and pregnancy].

B Karbowski1, C Jackisch

  • 1Frauenklinik ZKH St.-Jürgen-Strasse, Bremen.

Zeitschrift Fur Geburtshilfe Und Neonatologie
|September 29, 2000
PubMed
Summary

Malignant melanoma incidence is rising. This case highlights the challenges of managing advanced melanoma during pregnancy, emphasizing early diagnosis and interdisciplinary care for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

ESMO open·2025
Same author

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.

ESMO open·2025
Same author

[Predictive molecular diagnostics in breast cancer : What are the requirements for pathology today and in the future?]

Pathologie (Heidelberg, Germany)·2022
Same author

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Corrigendum to "A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study": [Annals of Oncology (2019), volume 30:1279-1288].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy<sup>⋆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Oncology
  • Dermatology
  • Obstetrics

Background:

  • Malignant melanoma incidence has significantly increased, with a notable proportion arising from melanocytes or preexisting nevi.
  • This report details a rare case of a pregnant woman with metastatic malignant melanoma.

Observation:

  • A 39-year-old pregnant woman presented with liver metastases two years post-melanoma surgery.
  • Despite progressive liver insufficiency leading to the mother's death, her premature infant (26 weeks + 4 days gestation) survived and developed normally.

Findings:

  • Early diagnosis and surgical excision are critical for malignant melanoma survival.
  • In advanced stages, chemotherapy does not appear to prolong survival.

Implications:

  • Managing malignant melanoma during pregnancy presents complex ethical and clinical challenges.
  • Close interdisciplinary collaboration among pediatricians, obstetricians, and oncologists is crucial for optimal patient and infant care.

Related Experiment Videos